Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances

First published: 13/03/2019 | Last updated: March 27th, 2019

Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances

Organisation: NEPTUNE
Web Address: http://neptune-clinical-guidance.co.uk/wp-content/uploads/2015/03/NEPTUNE-Guidance-March-2015.pdf

Document that provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and NPS. It categorises club drugs broadly according to their clinical effects: depressant; stimulant;  hallucinogenic.Synthetic cannabinoids are treated as a separate category, largely for reasons relating to their clinical management.Guidance is aimed in particular at clinicians in a range of settings – these are specialist drug treatment services; hospital emergency departments (EDs); general practice/ primary care; and sexual health clinics